CARDINAL BERNARDIN CANCER CENTER, LOYOLA UNIVERSITY

洛约拉大学芝加哥红衣主教贝尔纳丁癌症中心 理查德一世的方向Fisher，医学博士正在申请P-20癌症 中心规划补助金。 该中心是一个3500万美元，125,000平方米。 英尺提供最先进的诊所设施， 洛约拉的所有门诊癌症护理，34个新的研究实验室， 扩大基础/转化科学研究基地，核心空间 设施，办公室的所有教师从事全职在癌症相关 活动，行政和教育空间的校园和 社区外展活动。 癌症中心主任 负责分配所有临床和实验室空间， 该设施，招聘新的研究人员，和管理 机构业务预算。 1996年，临床项目 为超过10，000名患者提供服务，超过45，000次患者就诊， 以每年百分之十到十五的速度增长。 在过去 五年来，洛约拉附属医院有1408名患者登记 临床研究协议 该中心目前有四个独特的 研究项目：1）由Manuel迪亚兹博士领导的血液学研究， 理查德·费舍尔整合了白血病的遗传和临床研究， 淋巴瘤; 2）癌症免疫学，由凯瑟琳奈特和马丁博士领导 Kast整合了基础和应用肿瘤免疫学; 3）皮肤癌导致 Brian Nickoloff博士整合了基础和临床研究， 皮肤恶性肿瘤;和4）癌症的原因和预防领导博士。 理查德库珀，凯西阿尔班，和罗伯特弗拉尼根发展癌症 针对前列腺和乳腺的预防和控制举措 癌症，尤其是在少数民族地区。 当前年度联邦 癌症中心研究人员的资金超过830万美元。 这 规划拨款将是癌症中心的一个重要里程碑， 将使其继续快速增长和发展， 完成剩余的11个癌症中心的必要招聘 研究教师职位，发展所需的核心设施，扩大 跨学科的教师会议和研讨会，并刺激新的 翻译研究倡议。 在这笔赠款完成后， 红衣主教贝尔纳丁癌症中心计划定位为 成功申请P-30癌症中心支持补助金。

The Cardinal Bernardin Cancer Center of Loyola University Chicago under the direction of Richard I. Fisher, M.D. is applying for a P-20 Cancer Center Planning Grant. The Center is a 35 million dollar, 125,000 sq. ft. facility that provides state-of-the-art clinic facilities to house all of Loyola's outpatient cancer care, 34 new research laboratories to expand the basic/translational science research base, space for core facilities, offices for all faculty engaged full-time in cancer related activities, and administrative and educational space for campus and community outreach activities. The Cancer Center Director has responsibility for allocation of all clinical and laboratory space in this facility, recruitment of new research faculty, and administration of the institutional operating budget. In 1996, the clinical program served more than 10,000 patients with over 45,000 patient visits, representing an increase of 10-15 percent per year. During the last five years, Loyola affiliated hospitals had 1408 patient registrations onto clinical research protocols. The center currently has four unique Research Programs: 1) Hematologic Malignancy led by Drs. Manuel Diaz and Richard Fisher integrates genetic and clinical studies of leukemias and lymphoma; 2) Cancer Immunology led by Drs. Katherine Knight and Martin Kast integrates basic and applied tumor immunology; 3) Skin Cancer led by Dr. Brian Nickoloff integrates basic and clinical studies of cutaneous malignancies; and 4) Cancer Cause and Prevention led by Drs. Richard Cooper, Kathy Albain, and Robert Flanigan develops cancer prevention and control initiatives targeted toward prostate and breast cancer, especially in the minority communities. Current annual federal funding of Cancer Center investigators exceeds 8,300,000 dollars. This planning grant will be a critical milestone for the Cancer Center and will enable it to continue its rapid growth and development by completing necessary recruitment of the eleven remaining Cancer Center research faculty positions, developing needed core facilities, expanding interdisciplinary faculty meetings and seminars, and stimulating new translational research initiatives. At the completion of this grant, the Cardinal Bernardin Cancer Center plans to be positioned to successfully apply for a P-30 Cancer Center Support Grant.